⌘K
Loading ticker…
Achieve Life Sciences, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Achieve Life Sciences, Inc. (ACHV) has a 3-month relative strength percentile of 97 and a leadership percentile of 98 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 75. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.3%, relative volume 6.23×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 97, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ACHV is in a stage 2 uptrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 20.7% / 37.1%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
ACHV is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $5M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $5M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ACHV Jan avg: 23.76% median: 6.28% win: 50% σ: 51.99% n: 4 2022-04-12 → 2026-05-29 | ACHV Feb avg: -3.77% median: -3.16% win: 25% σ: 11.28% n: 4 2022-04-12 → 2026-05-29 | ACHV Mar avg: 0.97% median: -0.40% win: 50% σ: 32.63% n: 4 2022-04-12 → 2026-05-29 | ACHV Apr avg: 11.25% median: -2.62% win: 40% σ: 24.57% n: 5 2022-04-12 → 2026-05-29 | ACHV May avg: 9.99% median: 18.91% win: 60% σ: 24.02% n: 5 2022-04-12 → 2026-05-29 | ACHV Jun avg: -23.10% median: -22.78% win: 0% σ: 12.20% n: 4 2022-04-12 → 2026-05-29 (current) | ACHV Jul avg: 8.21% median: 6.93% win: 100% σ: 5.18% n: 4 2022-04-12 → 2026-05-29 | ACHV Aug avg: -4.70% median: -10.57% win: 25% σ: 12.62% n: 4 2022-04-12 → 2026-05-29 | ACHV Sep avg: -6.82% median: -3.80% win: 50% σ: 16.84% n: 4 2022-04-12 → 2026-05-29 | ACHV Oct avg: 5.43% median: -3.89% win: 25% σ: 40.53% n: 4 2022-04-12 → 2026-05-29 | ACHV Nov avg: 15.02% median: 10.91% win: 50% σ: 24.54% n: 4 2022-04-12 → 2026-05-29 | ACHV Dec avg: -14.87% median: -16.34% win: 25% σ: 13.11% n: 4 2022-04-12 → 2026-05-29 |